Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nigel Scott

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Drugs in Context|November 7, 2022
Small bowel villous atrophy due to immune-checkpoint inhibitors: report of two cases and literature reviewAnnalisa Schiepatti, Andrea Premoli, Stiliano Maimaris, et al.
Carcinogenesis|June 21, 2013
Reduced type II interleukin-4 receptor signalling drives initiation, but not progression, of colorectal carcinogenesis: evidence from transgenic mouse models and human case-control epidemiological observationsNicola Ingram, Emma L Northwood, Sarah L Perry, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 12, 2012
Early FDG PET response assessment of preoperative radiochemotherapy in locally advanced rectal cancer: correlation with long-term outcomeAntonio Avallone, Luigi Aloj, Corradina Caracò, et al.
Inflammatory Bowel Diseases|August 11, 2011
Treatment of colitis with a commensal gut bacterium engineered to secrete human TGF-β1 under the control of dietary xylan 1Zaed Z R Hamady, Nigel Scott, Mark D Farrar, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 7, 2008
Evidence and research in rectal cancerVincenzo Valentini, Regina Beets-Tan, Josep M Borras, et al.
Annals of Surgery|March 30, 2002
Rates of circumferential resection margin involvement vary between surgeons and predict outcomes in rectal cancer surgeryKevin F Birbeck, Christopher P Macklin, Nicholas J Tiffin, et al.
International Journal of Radiation Oncology, Biology, Physics|May 18, 2010
Oxaliplatin plus dual inhibition of thymidilate synthase during preoperative pelvic radiotherapy for locally advanced rectal carcinoma: long-term outcomeAntonio Avallone, Paolo Delrio, Biagio Pecori, et al.
The Lancet. Oncology|December 27, 2015
Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysisAndrew G Renehan, Lee Malcomson, Richard Emsley, et al.
Journal of Crohn'S & Colitis|April 28, 2022
Diagnostic Performance of Magnetic Resonance Enterography Disease Activity Indices Compared with a Histological Reference Standard for Adult Terminal Ileal Crohn's Disease: Experience from the METRIC TrialShankar Kumar, Thomas Parry, Sue Mallett, et al.
Annals of Surgery|June 24, 2005
The modern abdominoperineal excision: the next challenge after total mesorectal excisionRoger Marr, Kevin Birbeck, James Garvican, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Drugs in Context|November 7, 2022
Small bowel villous atrophy due to immune-checkpoint inhibitors: report of two cases and literature reviewAnnalisa Schiepatti, Andrea Premoli, Stiliano Maimaris, et al.
Carcinogenesis|June 21, 2013
Reduced type II interleukin-4 receptor signalling drives initiation, but not progression, of colorectal carcinogenesis: evidence from transgenic mouse models and human case-control epidemiological observationsNicola Ingram, Emma L Northwood, Sarah L Perry, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 12, 2012
Early FDG PET response assessment of preoperative radiochemotherapy in locally advanced rectal cancer: correlation with long-term outcomeAntonio Avallone, Luigi Aloj, Corradina Caracò, et al.
Inflammatory Bowel Diseases|August 11, 2011
Treatment of colitis with a commensal gut bacterium engineered to secrete human TGF-β1 under the control of dietary xylan 1Zaed Z R Hamady, Nigel Scott, Mark D Farrar, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 7, 2008
Evidence and research in rectal cancerVincenzo Valentini, Regina Beets-Tan, Josep M Borras, et al.
Annals of Surgery|March 30, 2002
Rates of circumferential resection margin involvement vary between surgeons and predict outcomes in rectal cancer surgeryKevin F Birbeck, Christopher P Macklin, Nicholas J Tiffin, et al.
International Journal of Radiation Oncology, Biology, Physics|May 18, 2010
Oxaliplatin plus dual inhibition of thymidilate synthase during preoperative pelvic radiotherapy for locally advanced rectal carcinoma: long-term outcomeAntonio Avallone, Paolo Delrio, Biagio Pecori, et al.
The Lancet. Oncology|December 27, 2015
Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysisAndrew G Renehan, Lee Malcomson, Richard Emsley, et al.
Journal of Crohn'S & Colitis|April 28, 2022
Diagnostic Performance of Magnetic Resonance Enterography Disease Activity Indices Compared with a Histological Reference Standard for Adult Terminal Ileal Crohn's Disease: Experience from the METRIC TrialShankar Kumar, Thomas Parry, Sue Mallett, et al.
Annals of Surgery|June 24, 2005
The modern abdominoperineal excision: the next challenge after total mesorectal excisionRoger Marr, Kevin Birbeck, James Garvican, et al.
Pageof 5